TLDR
- CCCX climbs as Infleqtion deal closes and INFQ NYSE debut nears Feb. 17.
- CCCX gains to $13.66; Infleqtion merger completes and NYSE trading starts Feb. 17.
- CCCX extends rally as Infleqtion confirms NYSE listing under INFQ and INFQ WS.
- CCCX up 3.37% as Infleqtion merger closes and ticker shift to INFQ approaches.
- CCCX jumps; Infleqtion set to trade on NYSE Feb. 17 after SPAC close.
Churchill Capital Corp X (CCCX) stock jumps as Infleqtion deal closes and NYSE debut nears, as shares closed at $13.66, up 3.37%. After-hours trading lifted the price to $13.80, up 1.02%, and kept momentum intact. The completed merger positions Infleqtion for a New York Stock Exchange debut on February 17, 2026.
Churchill Capital Corp X, CCCX
CCCX price action reflects merger close and delisting shift
Churchill Capital Corp X stock jumps as Infleqtion deal closes and NYSE debut nears, and the daily chart showed sharp movement. The stock dipped toward about $12.80 during the session and then recovered into the close. It later pushed near $13.90 before it consolidated under the $14 area.
Resistance formed near $14, while support held around $13.20 to $13.30 as trading settled. Meanwhile, the business combination completion removed the core deal uncertainty from the tape. As a result, the market treated the session as a transition day rather than a normal operating update.
Churchill Capital Corp X stock jumps as Infleqtion deal closes and NYSE debut nears, and the corporate structure also changed. Churchill X delisted from Nasdaq as the post-combination company prepared a new listing venue. In addition, the SPAC units separated and no longer traded as bundled units after closing.
INFQ common stock set for NYSE trading as neutral-atom platform goes public
Churchill Capital Corp X stock jumps as Infleqtion deal closes and NYSE debut nears, and the next catalyst is a ticker change. Infleqtion expects its common stock to begin trading on the NYSE on February 17, 2026. The planned ticker for the common shares is INFQ.
Infleqtion builds quantum computers, precision sensors, and software for governments, enterprises, and research institutions. The company focuses on neutral-atom technology and positions it as scalable and cost efficient. This single architecture supports both quantum computing and precision sensing from shared system design.
Churchill Capital Corp X stock jumps as Infleqtion deal closes and NYSE debut nears, and the deal frames a category milestone. Infleqtion describes itself as the first publicly listed neutral-atom quantum technology company. It also states it holds commercial leadership across computing and sensing in one public platform. The new listing expands public-market access to a neutral-atom focused operator.
INFQ WS warrants and unit separation formalize the post-merger capital stack
Churchill Capital Corp X stock jumps as Infleqtion deal closes and NYSE debut nears, and the warrant line also transitions. Infleqtion expects its warrants to trade on the NYSE under the symbol INFQ WS on February 17, 2026. Therefore, former Churchill X warrant holders will track price discovery under the new label. The shift aligns the capital stack with the renamed operating company.
The closing also ended trading for the SPAC’s units, since the IPO units already separated into shares and warrants. Consequently, the market will no longer price a combined unit instrument after the merger. This step follows the standard SPAC lifecycle from cash shell to operating issuer. It also reduces confusion across instruments during the listing move.
Churchill Capital Corp X stock jumps as Infleqtion deal closes and NYSE debut nears, and the timeline now looks clear. Nasdaq trading ended for Churchill X, while NYSE trading should start on February 17, 2026. Meanwhile, Infleqtion enters the public markets with products spanning quantum clocks, RF receivers, and inertial sensors. The transaction completes a route that has brought more quantum firms into public listings.


